Quick Verdict
ARA-290
Risk
Half-life
~3 hours
Cerluten
Risk
Half-life
—
Side-by-Side Comparison
About ARA-290
Non-hematopoietic EPO analogue; activates innate repair receptor (IRR/EPOR/CD131 complex) without erythropoietic effects; promotes tissue repair and nerve healing
A modified erythropoietin peptide that activates tissue repair pathways without stimulating red blood cell production. Strong evidence for neuropathic pain and sarcoidosis.
Research Areas
About Cerluten
CNS-targeted peptide complex that modulates neuronal gene expression. Shown in Russian clinical studies to improve memory consolidation, attention, and protect against neurodegeneration.
A short peptide bioregulator derived from brain and CNS tissue, developed by the Khavinson Institute. Studied for cognitive support, neuroprotection, and mitigation of age-related cognitive decline.
Research Areas
Find Providers
Where to source these peptides
Providers offering
ARA-290
12 listed
Browse directory →
Providers offering
Cerluten
1 listed
Browse directory →
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
More longevity Comparisons
Browse all peptides →Educational research tools — not medical advice.